VF
DALS

Virtu Financial’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Virtu Financial’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,100
Closed -$284K – 2335
2023
Q1 		$284K Buy
+28,100
New +$283K 0.03% 569
2021
Q4 		– Sell
-12,913
Closed -$127K – 2339
2021
Q3 		$127K Buy
+12,913
New +$128K 0.01% 1059

Other funds holding DALS

FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Virtu Financial's DALS Position: Q2 2023 in Review

Virtu Financial sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q2 2023, closing a stake of 28,100 shares — an estimated $284K sold.

Virtu Financial first reported a position in DALS in Q3 2021 and held it in 2 quarters. The position peaked at $284K in Q1 2023. 50 funds tracked by Wall St. Rank hold DALS as of Q2 2023.

  • Virtu Financial reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 28,100 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $284K.
  • Virtu Financial first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 2 quarters.
  • Virtu Financial's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $284K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.